Skip to search formSkip to main contentSkip to account menu

cancer immunotherapy

Known as: immunotherapy for cancer, immunotherapy cancer, cancer immunotherapies 
Use of techniques, biologically active substances, and procedures to enhance or restore the ability of the host immune system to fight cancer. Also… 
National Institutes of Health

Related topics

Related topics

2 relations

Narrower (1)

Adoptive Immunotherapy
Immunotherapy

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
Effective induction of anti-tumor immune responses with oligomannose-coated liposome targeting to intraperitoneal phagocytic cells.
2007
2007
DNA vaccines encoding IL-2 linked to HPV-16 E7 antigen generate enhanced E7-specific CTL responses and antitumor activity.
Highly Cited
2003
Highly Cited
2003
A novel approach to cancer immunotherapy: tumor cells decorated with CD80 generate effective antitumor immunity.
Malignant cells often elude the immune system by lacking costimulatory signals required for the generation of effective antitumor… 
Highly Cited
2002
Highly Cited
2002
patients with hematopoietic malignancies product in WT 1 Humoral immune responses against Wilms tumor gene
Kishimoto, Taisei Nomura and Haruo Sugiyama Tamotsu Yamagami, Akira Hiraoka, Machiko Tsukaguchi, Keiko Udaka, Hiroyasu Ogawa… 
Highly Cited
2000
Highly Cited
2000
Targeted cytokines for cancer immunotherapy
Targeting of cytokines into the tumor microenvironment using antibody-cytokine fusion proteins, called immunocytokines… 
Review
1999
Review
1999
Dendritic cell-based vaccine: a promising approach for cancer immunotherapy
The unique ability of dendritic cells to pick up antigens and to activate naive and memory CD4+ and CD8+ T cells raised the… 
Review
1999
Review
1999
Interleukin-12 as an adjuvant for cancer immunotherapy.
Interleukin-12 (IL-12) is a cytokine whose main effect is to drive Th-cell differentiation throughout a T helper type 1 cell type… 
Highly Cited
1997
Highly Cited
1997
Natural killer cell lines kill autologous beta2-microglobulin-deficient melanoma cells: implications for cancer immunotherapy.
Cancer vaccines used to generate specific cytotoxic T lymphocytes are not effective against tumor cells that have lost or… 
Highly Cited
1997
Highly Cited
1997
Generation of dendritic cells in vitro from peripheral blood mononuclear cells with granulocyte-macrophage-colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha for use in cancer…
OBJECTIVE The purpose of the study was to characterize the requirements in terms of precursors, developmental pathways, and media… 
Highly Cited
1973
Highly Cited
1973
An experimental screening for "systemic adjuvants of immunity" applicable in cancer immunotherapy.
Ten agents, Bacillus Calmette-Guerin , methanol extract residual and two other extracts of mycobacteria, Corynebacterium parvum… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)